MedTrace Logo

Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia

NCT00383799 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2016-04-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether intravenous amiodarone has less cardiac significant adverse events compared to intravenous procainamide in the acute treatment of haemodynamically well tolerated wide QRS tachycardia, the majority of them of probably ventricular origen.

Conditions

  • Ventricular Tachycardia
  • Wide QRS Tachycardia

Interventions

DRUG

iv Amiodarone

DRUG

iv Procainamide

Sponsors & Collaborators

  • Hospital General Universitario Gregorio Marañon

    lead OTHER

Principal Investigators

  • Jesús Almendral, MD · Hospital General Universitario Gregorio Marañón. Madrid. Spain

  • Fernando Arribas, MD · Hospital General Universitario 12 de Octubre. Madrid. Spain

  • Rafael Peinado, MD · Hospital General Universitario La Paz. Madrid. Spain

  • Alfonso Martín, MD · Hospital de Móstoles. Madrid. Spain

  • Carmen del Arco, MD · Hospital de la Princesa. Madrid. Spain

  • Dolores Vigil, MD · Hospital general Universitario Gregorio Marañón. Madrid. Spain

  • Mercedes Ortiz, PhD · Hospital General Universitario Gregorio Marañón. Madrid. Spain

  • Blanca Coll-Vinent, MD · Hospital Clinic. Barcelona. Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383799 on ClinicalTrials.gov